Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesPharmacotherapy of Addictive Disorders
Clinical Neuropharmacology, 10/09/09
Ross S et al. – Opiate addiction is treated by approved agonist and antagonist mu–opioid medications with the future potential for agents that can modulate the stress systems and the iboga alkaloids. Although no pharmacotherapies are currently approved for cocaine addiction, promising lines of research include agents that affect dopaminergic, GABAergic, serotonergic, and glutamatergic systems as well as the promise for immune therapies.
Related Articles
The Neurobiology of Addictive Disorders
Clinical Neuropharmacology, 10/13/09
Relevance Score: 68%
Functional and Dysfunctional Synaptic Plasticity in Prefrontal Cortex: Roles in Psychiatric Disorders
Biological Psychiatry, 10/26/09
Relevance Score: 67%
Cholinergic Functioning in Stimulant Addiction: Implications for Medications Development
CNS Drugs, 10/26/09
Relevance Score: 66%
Predictive Values of Psychiatric Symptoms for Internet Addiction in Adolescents
Archives of Pediatrics and Adolescent Medicine, 10/07/09
Relevance Score: 66%
Instant Messaging Addiction among Teenagers in China: Shyness, Alienation, and Academic Performance Decrement
CyberPsychology & Behavior, 10/01/09
Relevance Score: 65%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Functional Magnetic Resonance Imaging of Effects of a Nicotinic Agonist in Schizophrenia
Neuropsychopharmacology, 12/15/09
Treatment with Olanzapine is Associated with Modulation of the Default Mode Network in Patients with Schizophrenia
Neuropsychopharmacology, 12/15/09
An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas
Journal of Pharmacy and Pharmacology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor